# s160 round 2 adjudication (chat 5, 2026-11-01, Claude lead)

Receipts: repair/efficiency/lanes/s160/r2/<part>-<group>/<card>/receipt.md. "rep N" = that receipt's replacement N.
Verdicts: acc pc-benzo PASS, pc-sleep PASS, adhd-meds PASS-IF, pc-orexin FAIL (1 MED), sud-meds PASS; read pc-benzo PASS,
pc-anxiety PASS-IF, pc-sleep PASS-IF, adhd-meds FAIL (1 MED), pc-orexin FAIL (1 MED), sud-meds PASS-IF; flags pc-anxiety,
pc-sleep (receipt saved by the lead; budget ran out), adhd-meds, pc-orexin, sud-meds PASS-IF. 0 HIGH.

## Fixes for chat 6 (apply in each card's author.py; grep STANDING and DIGEST for the topic first)

pc-anxiety
1. Buspirone "In practice" hover: flags-A rep (LOW 2) wording: "Anxiety symptoms typically ease only once the dose
   reaches the upper range; buspirone is taken on a schedule, not as a rescue dose" (read-A LOW same point).
2. Hydroxyzine adverse-effects line: move "see Anticholinergic delirium below" before the pc-uv flag in author.py
   (structural; read-A and flags-A LOW 3), so the flag ends the line.
3. REJECT flags-A LOW 1 ("and falls" unsourced): the line carries the pc-uv mark; the r1 acc note judges a pc-uv line on
   truth, and falls from a sedating anticholinergic in an older adult is true. Kept.
4. Pregabalin adverse effects (S6, flags-A note): look for a cached pregabalin (Lyrica) label in the web cache; if found,
   add "Pregabalin: dizziness, sleepiness, peripheral edema, weight gain" with its label fact; if not, report item
   (no fetch spent unless cheap).

pc-sleep
5. read-A F1: the RBD line's peds-sleep chip: confirm with pagelib that peds-sleep teaches REM sleep behavior disorder
   (a crude scan of local/s160/index.html says yes); drop the chip only if not.
6. REJECT read-A F2 (parallel order): the line follows the card's "drug: use" pattern (acc-A agrees).
7. read-A F3: "No board source tests it." in two hovers: read-A rep for it.
8. 5 mg repeat: flags-A rep 1 (read-A F4 same point).
9. read-A F5: the unhedged "No significant day-after psychomotor depression or amnesia" line: read-A rep.
10. Driving Why cell: flags-A rep 2 "Zolpidem label: next-day impairment if under 7 to 8 hours in bed" (read-A F6 same).
11. flags-A F3 (lead, s06 has no Z-drug comparison): rep 3 "Diphenhydramine is no better choice: heavy sedation for
    questionable benefit".

pc-orexin
12. MED acc-B: Before starting masked Check "liver disease (not recommended when severe)" -> "liver disease" (the label
    nuance stays in the Key point hover).
13. MED read-B: narcolepsy danger commit (masked) back to class-only: "any option other than an orexin antagonist" (the
    r1 text). This also closes flags-B LOW 3 (no CBT-I source on that line).
14. read-B LOW: Where line "behavioral therapy first" -> "cognitive behavioral therapy for insomnia first" (read-B rep 1).
15. Monitoring row 3 Why (acc-B LOW, flags-B LOW 2): "Label warnings, one of them dose-related; one of them means
    stopping the drug" (acc-B wording; naming suicidal ideation would unmask the Check).
16. flags-B LOW 1: "Suicidal ideation, dose-related (suvorexant label)".
17. acc-B earlier finding 3 (never adjudicated): requote dq1 as the full Quviviq contraindication sentence (facts only;
    cached label).

adhd-meds
18. MED read-B: guanfacine/clonidine Monitoring Why -> "Rebound after a stop" (read-B rep 1).
19. Mania line (acc-B, read-B, flags-B LOW): flags-B wording "New psychotic or manic symptoms are a label warning; in
    diagnosed bipolar disorder, a small risk of switching to mania" (p11b).
20. read-B LOW: atomoxetine Monitoring row label: read-B rep 3.
21. flags-B LOW 2: Mania row "points to" -> flags-B rep (k13 "more consistent with").

sud-meds
22. read-B LOW 1: chart Why -> "a long half-life keeps the agonist in the body" (not read-B's "on the receptor": the
    receptor-residence claim was cut in round 1 as unsourced).
23. read-B LOW 2: hover title "Neuropsychiatric warning" -> "Label warning".
24. flags-B LOW 1: "after methadone, precipitated withdrawal may be more likely" (flags-B rep 1).
25. flags-B LOW 2: Monitoring Why "A sometimes fatal organ injury that may develop even after months" (flags-B rep 2).

## Round 3 (S7) after the fixes
The three MEDs are text-level and their fixes restore reviewed text, so round 3 is narrow: acc pc-orexin; read
adhd-meds and pc-orexin (one Sonnet lane), each --since its r2 packet (packets/s160r2/<id>/acc/brief_text.txt). The
LOW-only parts close on the lead's S6 check of each replacement. Budget left for reviewers: 4 agents, 175 calls,
2.95M tokens (wave 21 agents, 635 calls, 54.65M of 57.6M).
